Immunoassays from discovery to the clinic
Gyros immunoassay platform in action at:
MedImmune
GlaxoSmithKline
Pfizer
Merck
MerckSerono
ICON
Amgen
AstraZeneca
Novartis
Recipharm
Bristol-Myers Squibb Company
Thrombogenics
Quotient Bioresearch
Radix Biosolutions
Rentschler Biotechnologie
Roche
Royal Institute of Technology
ProBioGen
York Bioanalytical Solutions
Syrinx Bioanalytics
Rudbeck Laboratory
National Veterinary Institute
Huntingdon Life Sciences
GE Healthcare Bio-Sciences
Cedra Corporation
Biogen Idec
PhaseBio Pharmaceuticals
National Research Centre for the Working Environment (AMI)
Novo Nordisk
NovImmune
Ablynx
Predictive Physiology & Medicine, Inc.
Enables us to make significant gains in assay quality, performance and productivity
J. Allinson, ICON Development Solutions
Gyros news |
 |
Upcoming events |
|
In focus |